Full-Time

Senior Research and Development Engineer

Medical Devices

Posted on 9/19/2025

Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$90.2k - $128.7k/yr

Company Does Not Provide H1B Sponsorship

Mansfield, MA, USA

Hybrid

Hybrid position requiring 3+ days onsite.

Category
Aerospace Engineering (1)
Required Skills
CAD
Risk Management
SolidWorks
Requirements
  • Bachelor’s Degree or higher in Biomedical Engineering, Mechanical Engineering, or related field, preferred or equivalent work experience.
  • 2 – 5 years of relevant medical device experience, preferred.
  • A minimum of 2+ years related work experience preferred.
  • Ability to work independently and as a member of a team.
  • Knowledge of Medical Device design controls and Stage Gate product development process, preferred.
  • Applies comprehensive knowledge and a thorough understanding of concepts, principles, and technical capabilities to perform varied tasks and projects.
  • Self-Driven/Motivated/Proactive & Strong Background in Multitasking
  • Strong written, verbal, and presentation skills
  • Ability to thrive in a dynamic environment.
  • Proven track record of successful technical project management in a product development environment
  • Knowledge of Plastics Injection Molding Designs, preferred.
  • Knowledge of mechanical systems and component level design.
  • Experience with CAD preferably SolidWorks.
  • MS office tools including Word, Excel, PowerPoint, Project.
  • Design for Six Sigma (DFSS) trained and certified is a plus.
  • Manufacturing and Patent Experience is a plus.
  • Non-Woven, the Converting of Non-woven is a plus.
  • Urology, Folly Catheters, Drain Bags is a plus.
Responsibilities
  • Contribute to the development and maintenance of Medical Devices.
  • Effectively and thoughtfully incorporate required regulatory medical device standards (FDA, ISO, IEC, EN).
  • This position will work on complex projects of large scope and will provide technical leadership for Medical Device 510k submissions for new products.
  • Contribute to the development of policies and procedures.
  • Construct Design History Files in accordance with SOP’s.
  • Write protocols and reports for various technical aspects including design verifications and validations, as well as provide solutions and implementations using established Change Development Process.
  • Conduct and/or orchestrate device and component testing.
  • Conduct product development tasks & documentation required to satisfy design controls and risk management in accordance with established SOPs.
  • Provide presentations, reports and schedules as required to manage projects and to communicate status, risks and issues.
  • The ability to work with a diverse team in various locations in the US, Asia and other location will be required. This will include Quality, Regulatory, Manufacturing, and other technical groups such as 3rd party design engineering resources.
  • Excellent personal and team leadership skills may act as mentor to less experienced colleagues.
  • Product transfer from R&D to manufacturing.
  • Travel to support and Drive Projects, no more than 5%.
Desired Qualifications
  • Knowledge of Medical Device design controls and Stage Gate product development process, preferred.
  • Knowledge of Plastics Injection Molding Designs, preferred.
  • Design for Six Sigma (DFSS) trained and certified is a plus.
  • Manufacturing and Patent Experience is a plus.
  • Non-Woven, the Converting of Non-woven is a plus.
  • Urology, Folly Catheters, Drain Bags is a plus.

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for hospitals, clinics, and pharmacies worldwide. The company operates a global logistics network to deliver supplies while providing data tools that help healthcare facilities track inventory and improve operational efficiency. Unlike many niche suppliers, Cardinal Health combines 50 years of experience with a massive scale that covers both the physical supply chain and the software needed to manage it. Its goal is to streamline the healthcare supply chain to ensure providers have reliable access to essential products while reducing costs and improving patient care.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Majority stake in GI Alliance in November 2024 accelerates gastroenterology growth.
  • Acquired Advanced Diabetes Supply Group in November 2024 boosts at-Home Solutions.
  • Added Solaris Health urology MSO in August 2025 to Specialty Alliance platform.

What critics are saying

  • McKesson erodes specialty share with superior pharmacy analytics within 12-24 months.
  • Cencora undercuts generics pricing, squeezing margins in 6-12 months.
  • DEA quotas cut $500M opioid revenue comprising 20% sales in 3-6 months.

What makes Cardinal Health unique

  • Acquired Specialty Networks in January 2024 for multi-specialty GPOs in urology and gastroenterology.
  • Launched Kendall DL™ Multi System in June 2025 for continuous vital signs monitoring.
  • Expanded Actinium-225 production in April 2026 for novel cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...

INACTIVE